Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

Resistance to L-asparaginase in leukemic cells may be caused by an elevated cellular expression of asparagine synthetase (AS). Previously, we reported that high AS expression did not correlate to L-asparaginase resistance in TEL-AML1-positive B-lineage acute lymphoblastic leukemia (ALL). In the present study we confirmed this finding in TEL-AML1-positive patients (n = 28) using microarrays. In contrast, 35 L-asparaginase-resistant TEL-AML1-negative B-lineage ALL patients had a significant 3.5-fold higher AS expression than 43 sensitive patients (P < .001). Using real-time quantitative polymerase chain reaction (RTQ-PCR), this finding was confirmed in an independent group of 39 TEL-AML1-negative B-lineage ALL patients (P = .03). High expression of AS was associated with poor prognosis (4-year probability of disease-free survival [pDFS] 58% +/- 11%) compared with low expression (4-year pDFS 83% +/- 7%; P = .009). We conclude that resistance to l-asparaginase and relapse risk are associated with high expression of AS in TEL-AML1-negative but not TEL-AML1-positive B-lineage ALL.

[1]  M. D. Boer,et al.  Upregulation of asparagine synthetase and cell cycle arrest in t(12;21)-positive ALL , 2005, Leukemia.

[2]  Cheng Cheng,et al.  Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. , 2004, The New England journal of medicine.

[3]  O. Hrusak,et al.  Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells , 2004, Leukemia.

[4]  M. D. Boer,et al.  Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. D. Den Boer,et al.  Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. , 2003, Blood.

[6]  G. Guidotti,et al.  Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis , 2001, Cell Death and Differentiation.

[7]  M. Kilberg,et al.  Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells. , 2001, The Biochemical journal.

[8]  M. Kilberg,et al.  Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. , 2001, The Biochemical journal.

[9]  F. Uckun,et al.  Chemosensitivity of TEL-AML1 Fusion Transcript Positive Acute Lymphoblastic Leukemia Cells , 2001, Leukemia & lymphoma.

[10]  R. Pieters,et al.  TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. , 2000, Blood.

[11]  R. Pieters,et al.  Asparagine synthetase activity in paediatric acute leukaemias: AML‐M5 subtype shows lowest activity , 2000, British journal of haematology.

[12]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.

[13]  S. Schuster,et al.  Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. , 1997, American Journal of Physiology.

[14]  S. Schuster,et al.  An investigation into the mechanism ofl-asparaginase resistance in L5178Y murine leukemia cells , 1993, Amino Acids.

[15]  I. Andrulis,et al.  Hypomethylation and reactivation of the asparagine synthetase gene induced by L-asparaginase and ethyl methanesulfonate. , 1991, Cancer research.

[16]  H. Mikawa,et al.  Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase. , 1989, Leukemia.

[17]  J. Holland,et al.  Biochemical and pharmacological studies with asparaginase in man. , 1970, Cancer research.

[18]  C. Haskell,et al.  l-asparaginase resistance in human leukemia--asparagine synthetase. , 1969, Biochemical pharmacology.

[19]  M. Prager,et al.  Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas. , 1968, Biochemical and biophysical research communications.

[20]  R. Gelber,et al.  Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia. , 1999, Journal of pediatric hematology/oncology.

[21]  R. Pieters,et al.  In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. , 1997, Blood.

[22]  M. Baliś,et al.  Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy. , 1969, Cancer research.